Search by Drug Name or NDC
NDC 61874-0160-30 Vraylar 6 mg/1 Details
Vraylar 6 mg/1
Vraylar is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is CARIPRAZINE.
MedlinePlus Drug Summary
Cariprazine is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Cariprazine is also used to treat episodes of depression in people with bipolar I disorder (manic depressive disorder; a disease that causes episodes of mania, episodes of depression and other abnormal moods). It is also used as a short term treatment for episodes of mania or mixed episodes (symptoms of mania and depression that happen together) in people with bipolar I disorder. Cariprazine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
Related Packages: 61874-0160-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cariprazine
Product Information
| NDC | 61874-0160 |
|---|---|
| Product ID | 61874-160_e342dd19-ed3b-4a30-b5ea-a17b3638e741 |
| Associated GPIs | 59400018100150 |
| GCN Sequence Number | 074810 |
| GCN Sequence Number Description | cariprazine HCl CAPSULE 6 MG ORAL |
| HIC3 | H8W |
| HIC3 Description | ANTIPSYCHOTIC-ATYPICAL,D3/D2 PARTIAL AG-5HT MIXED |
| GCN | 39584 |
| HICL Sequence Number | 042552 |
| HICL Sequence Number Description | CARIPRAZINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Vraylar |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | cariprazine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, GELATIN COATED |
| Route | ORAL |
| Active Ingredient Strength | 6 |
| Active Ingredient Units | mg/1 |
| Substance Name | CARIPRAZINE |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Atypical Antipsychotic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA204370 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61874-0160-30 (61874016030)
| NDC Package Code | 61874-160-30 |
|---|---|
| Billing NDC | 61874016030 |
| Package | 30 CAPSULE, GELATIN COATED in 1 BOTTLE (61874-160-30) |
| Marketing Start Date | 2016-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 46.1627 |
| Pricing Unit | EA |
| Effective Date | 2024-01-02 |
| NDC Description | VRAYLAR 6 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |